Safety of intravenous iron formulations: facts and folklore
- PMID: 25074787
- PMCID: PMC4111808
- DOI: 10.2450/2014.0094-14
Safety of intravenous iron formulations: facts and folklore
Comment in
-
Intravenous iron and safety: is the end of the debate on the horizon?Blood Transfus. 2014 Jul;12(3):287-9. doi: 10.2450/2014.0144-14. Blood Transfus. 2014. PMID: 25074522 Free PMC article. No abstract available.
References
-
- Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369:481–3. - PubMed
-
- Barton J, Barton E, Bertoli L, et al. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. Am J Med. 2000;109:27–32. - PubMed
-
- Wysoski D, Swartz L, Borders-Hemphill V, et al. Use of parenteral iron products and serious anaphylactic-type reaction. Am J Hematol. 2010;86:650–4. - PubMed
-
- Auerbach M, Kane R. Caution in making references from FDA’s adverse event reporting system. Am J Health System Pharmacy. 2012;11:922–3. - PubMed
-
- Baird I, Podmore D. Intramuscular iron therapy in iron deficiency anaemia. Lancet. 1954;267:942–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical